HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in ADC Online Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Harpin, V A Search for Related Content PubMed PubMed Citation Articles by Harpin, V A Topic Collections Relevant Article

The effect of ADHD on the life of an individual, their family, and community from preschool to adult life

Correspondence to:
Correspondence to:
Dr V A Harpin
Ryegate Children’s Centre, Sheffield Children’s NHS Trust, Tapton Crescent Road, Sheffield S10 5DD, UK; Val.Harpin{at}sheffch-tr.trent.nhs.uk

ABSTRACT
Attention deficit/hyperactivity disorder (ADHD) may affect all aspects of a child’s life. Indeed, it impacts not only on the child, but also on parents and siblings, causing disturbances to family and marital functioning. The adverse effects of ADHD upon children and their families changes from the preschool years to primary school and adolescence, with varying aspects of the disorder being more prominent at different stages. ADHD may persist into adulthood causing disruptions to both professional and personal life. In addition, ADHD has been associated with increased healthcare costs for patients and their family members.

Abbreviations: CHQ, Child Health Questionnaire; ODD, oppositional defiant disorder

Relevant Article

Introduction

P Hill
Arch. Dis. Child. 2005 90: i1. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				J. Conway, K. K. Wong, C. O'Connell, and A. E. Warren Cardiovascular Risk Screening Before Starting Stimulant Medications and Prescribing Practices of Canadian Physicians: Impact of the Health Canada Advisory Pediatrics, October 1, 2008; 122(4): e828 - e834. [Abstract] [Full Text] [PDF]

				V A Harpin Medication options when treating children and adolescents with ADHD: interpreting the NICE guidance 2006 Arch. Dis. Child. Ed. Pract., April 1, 2008; 93(2): 58 - 65. [Abstract] [Full Text] [PDF]

				A. Caspi, K. Langley, B. Milne, T. E. Moffitt, M. O'Donovan, M. J. Owen, M. Polo Tomas, R. Poulton, M. Rutter, A. Taylor, et al. A Replicated Molecular Genetic Basis for Subtyping Antisocial Behavior in Children With Attention-Deficit/Hyperactivity Disorder Arch Gen Psychiatry, February 1, 2008; 65(2): 203 - 210. [Abstract] [Full Text] [PDF]

				T. Anders, S. Sharfstein, M. D. Rappley, J. W. Moore, D. Dokken, L. Wojnowski, and S. E. Nissen ADHD drugs and cardiovascular risk. N. Engl. J. Med., May 25, 2006; 354(21): 2296 - 2298. [Full Text] [PDF]

				J. Mill, A. Caspi, B. S. Williams, I. Craig, A. Taylor, M. Polo-Tomas, C. W. Berridge, R. Poulton, and T. E. Moffitt Prediction of heterogeneity in intelligence and adult prognosis by genetic polymorphisms in the dopamine system among children with attention-deficit/hyperactivity disorder: evidence from 2 birth cohorts. Arch Gen Psychiatry, April 1, 2006; 63(4): 462 - 469. [Abstract] [Full Text] [PDF]